Safety
-
Chantix (varenicline)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2010
ADVERSE REACTIONS
Postmarketing Experience
- There have been reports of myocardial infarction (MI) and cerebrovascular accident (CVA) including ischemic and hemorrhagic events in patients taking Chantix
-
-







